Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Chitosan-based Advanced Materials For Docetaxel And Paclitaxel Delivery: Recent Advances And Future Directions In Cancer Theranostics.

M. Ashrafizadeh, Z. Ahmadi, N. Mohamadi, A. Zarrabi, Sara Abasi, Gholamreza Dehghannoudeh, Rosette N Tamaddondoust, H. Khanbabaei, R. Mohammadinejad, V. K. Thakur
Published 2019 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor activity against various cancer cells. These chemotherapeutic agents suffer from a number of drawbacks and it seems that low solubility in water is the most important one. Although much effort has been made in improving the bioavailability of PTX and DTX, the low bioavailability and minimal accumulation at tumor sites are still the challenges faced in PTX and DTX therapy. As a consequence, biomaterial-synthesized NPs have attracted much attention due to unique properties. Among them, chitosan (CS) is of interest due to its great biocompatibility. CS is a positively charged polysaccharide with the capability of interaction with negatively charged biomolecules. Besides, it can be processed into the sheet, micro/nano-particles, scaffold, and is dissolvable in mildly acidic pH similar to the pH of the tumor microenvironment. Keeping in mind the different applications of CS in the preparation of nanocarriers for delivery of PTX and DTX, in the present review, we demonstrate that how CS functionalized-nanocarriers and CS modification can be beneficial in enhancing the bioavailability of PTX and DTX, targeted delivery at tumor site, image-guided delivery and co-delivery with other anti-tumor drugs or genes.
This paper references
10.2147/IJN.S164518
Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends
M. Sohail (2018)
10.1021/bm4004805
Intracellular drug delivery nanocarriers of glutathione-responsive degradable block copolymers having pendant disulfide linkages.
Behnoush Khorsand (2013)
10.1016/S0378-5173(01)00986-3
Paclitaxel and its formulations.
A. K. Singla (2002)
10.4014/jmb.1903.03022
WITHDRAWN:Nano-encapsulation of plant growth promoting rhizobacteria and their metabolites using alginate-silica nanoparticles and carbon nanotube improves UCB1 pistachio micropropagation.
Mojde Moradipour (2019)
10.1016/j.ijpharm.2018.03.017
Effective deactivation of A549 tumor cells in vitro and in vivo by RGD‐decorated chitosan‐functionalized single‐walled carbon nanotube loading docetaxel
B. Li (2018)
10.1016/j.ijbiomac.2014.06.009
Chitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cells.
S. Maya (2014)
10.1039/C5RA08550K
An insight into cochleates, a potential drug delivery system
A. Pawar (2015)
10.1021/bm400406x
Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel.
Nitin Joshi (2013)
10.1016/j.ijpharm.2017.09.023
Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Yonglong Zhang (2017)
10.3390/ijms15033519
Docetaxel-Loaded Chitosan Microspheres as a Lung Targeted Drug Delivery System: In Vitro and in Vivo Evaluation
H. Wang (2014)
10.1021/mp400340k
Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Xiang Jin (2014)
10.1016/j.carbpol.2012.03.010
Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios.
Susana Rodrigues (2012)
10.1016/j.carbpol.2018.07.057
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats.
C. Intini (2018)
10.2147/CMAR.S198624
SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer
S. Zheng (2019)
10.1016/j.carbpol.2018.10.096
Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel.
X. Wang (2019)
10.3109/1061186X.2015.1054829
Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel
Sara A Abouelmagd (2015)
10.1016/S1357-4310(99)01615-9
Causes and consequences of tumour acidity and implications for treatment.
M. Stubbs (2000)
10.1016/j.biomaterials.2017.07.004
Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic.
A. K. Pearce (2017)
10.1016/S0960-894X(97)10128-7
First synthesis and cytotoxic activity of novel docetaxel analogs modified at the C18-position
K. Uoto (1997)
10.22123/PHJ.2018.130469.1007
Antifungal nanoparticles reduce aflatoxin contamination in pistachio
Fatemeh Hassanzadeh Davarani (2018)
10.1080/09205063.2015.1101259
Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation
J. Yu (2015)
10.1016/j.biomaterials.2011.12.034
The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier.
R. Rosenthal (2012)
10.3390/biom9100530
Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems
Shima Tavakol (2019)
10.1007/s13346-017-0357-8
Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery
A. Almeida (2017)
10.1016/j.jconrel.2011.08.166
Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery.
Huofei Zhou (2011)
10.1200/JCO.2005.11.890
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.
J. Baselga (2005)
10.1016/j.jare.2019.01.004
Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review
R. Mohammadinejad (2019)
10.1016/j.carbpol.2018.11.099
Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.
Guowei Qu (2019)
10.1016/j.colsurfb.2016.08.059
Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Mukesh K. Nag (2016)
10.1080/10717544.2017.1378938
In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma
Fang Xie (2017)
10.1007/s10620-017-4682-z
BMI Is a Risk Factor for Colorectal Cancer Mortality
A. Shaukat (2017)
10.1080/21691401.2018.1453831
Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting
Ishwor Poudel (2018)
10.1016/j.ijbiomac.2014.06.029
Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies.
Ankit Jain (2014)
10.3892/or.2014.3344
Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors.
Rong-Feng Song (2014)
10.1016/j.jconrel.2013.08.297
Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Heebeom Koo (2013)
10.1007/978-3-030-16538-3_1
Historical Landmarks in the Discovery of Chitin
G. Crini (2019)
10.2147/IJN.S15500
Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
S. Saremi (2011)
10.1016/J.COLSURFB.2004.09.002
Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system.
C. Zhang (2004)
10.1080/03007995.2017.1341869
Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature
N. Summers (2017)
10.1016/j.jconrel.2008.07.024
Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC.
Xiaoli Hui (2008)
10.1016/j.ijbiomac.2011.12.034
Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
J. Xu (2012)
10.1021/mp300051h
Targeted delivery of insoluble cargo (paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD).
P. Lv (2012)
10.1155/2013/150478
Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
S. Saremi (2013)
10.1016/j.jconrel.2008.01.004
Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
B. S. Zolnik (2008)
10.2174/156720106778559047
Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
M. Ishihara (2006)
10.2174/1871520616666160502122724
Breast Cancer: Current Molecular Therapeutic Targets and New Players.
S. Nagini (2017)
10.1517/17425247.2016.1134484
Recent advances in testing of microsphere drug delivery systems
Janki V Andhariya (2016)
10.18632/oncotarget.13757
Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery
Li-chun Cheng (2017)
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
L. Gerweck (1996)
10.1208/pt070250
Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note
D. Bhumkar (2008)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1177/0885328215579297
Codelivery of paclitaxel and small interfering RNA by octadecyl quaternized carboxymethyl chitosan-modified cationic liposome for combined cancer therapy
Ran Zhang (2015)
10.1002/jps.23995
Development of a thermally responsive nanogel based on chitosan-poly(N-isopropylacrylamide-co-acrylamide) for paclitaxel delivery.
Y. Wang (2014)
10.1016/S0939-6411(03)00095-X
A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel.
È. Ruel-Gariépy (2004)
10.1016/j.carbpol.2013.01.013
Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
Zheng Pan (2013)
10.1016/j.jconrel.2015.04.009
A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Anna Scomparin (2015)
10.1016/j.ejpb.2012.10.017
Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.
Daniel Torrecilla (2013)
10.3802/jgo.2018.29.e96
Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
Matilda X Lee (2018)
10.1208/s12249-014-0077-z
Efficacy, Pharmacokinetics, and Biodistribution of Thermosensitive Chitosan/β-Glycerophosphate Hydrogel Loaded with Docetaxel
Cuiyun Li (2014)
10.2147/IJN.S188667
Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin– chitosan nanoparticles loading paclitaxel– cholesterol complex
Xiao-Yang Chu (2019)
10.1186/1471-2121-10-63
A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy
B. Chen (2009)
10.2217/nnm.10.135
Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel.
W. Trickler (2011)
10.1016/S0140-6736(13)62224-2
Global cancer patterns: causes and prevention
P. Vineis (2014)
10.1248/CPB.58.1423
Chitosan nanoparticles: a promising system in novel drug delivery.
K. Nagpal (2010)
10.22038/ijbms.2019.32873.7852
Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
M. Hatamipour (2019)
10.2174/1872211309666150611120724
Opinion Paper: Nanotechnology: A Successful Approach to Improve Oral Bioavailability of Phytochemicals.
A. Shakeri (2016)
10.1016/J.COLSURFB.2005.06.001
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Quan Gan (2005)
10.1007/s11095-014-1337-z
Solid Lipid Particles for Oral Delivery of Peptide and Protein Drugs II – The Digestion of Trilaurin Protects Desmopressin from Proteolytic Degradation
P. C. Christophersen (2014)
10.3109/03639045.2012.694588
Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel
J. Wu (2013)
10.3389/fonc.2019.00642
Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study
W. Wang (2019)
10.1016/j.carbpol.2015.10.012
Fabrication, characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles.
Ankit Jain (2016)
10.1016/J.JPBA.2006.01.011
A stability-indicating HPLC assay method for docetaxel.
B. M. Rao (2006)
10.1007/s11095-009-9911-5
The In vitro Sub-cellular Localization and In vivo Efficacy of Novel Chitosan/GMO Nanostructures containing Paclitaxel
W. Trickler (2009)
10.2217/nnm-2016-0371
Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
J. Campos (2017)
10.1038/srep26895
Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity
Guru R Valicherla (2016)
10.1111/jphp.13006
Paclitaxel delivery system based on poly(lactide‐co‐glycolide) microparticles and chitosan thermo‐sensitive gel for mammary adenocarcinoma treatment
J. Pesoa (2018)
10.1080/10601329409349743
Release Behavior of 5-Fluorouracil from Chitosan-Gel Nanospheres Immobilizing 5-Fluorouracil Coated with Polysaccharides and Their Cell Specific Cytotoxicity
Y. Ohya (1994)
10.1016/j.ijpharm.2011.12.004
α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
N. Liang (2012)
10.1021/acs.langmuir.8b02809
Self-Assembled Reduced Albumin and Glycol Chitosan Nanoparticles for Paclitaxel Delivery.
M. Razi (2019)
10.1016/j.biomaterials.2013.02.030
Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
W. Wei (2013)
10.1016/j.ijbiomac.2018.12.262
Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
E. Zhang (2019)
10.1088/0957-4484/19/14/145101
Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel.
Yin-Song Wang (2008)
10.3390/ijms20143383
Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
J. Liu (2019)
10.1016/j.carbpol.2014.04.038
Layer-by-layer assembly of chitosan stabilized multilayered liposomes for paclitaxel delivery.
Meng-xia Chen (2014)
10.1016/j.colsurfb.2014.06.068
Crosslinked triblock copolymeric micelle for redox-responsive drug delivery.
Yin Lv (2014)
10.1016/j.critrevonc.2013.06.009
Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma.
J. Cadranel (2013)
10.1016/j.ijpharm.2015.07.022
Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Z. Yuan (2015)
10.3322/caac.21262
Global cancer statistics, 2012
L. Torre (2015)
10.1016/j.ijbiomac.2018.02.069
An injectable chitosan/chondroitin sulfate hydrogel with tunable mechanical properties for cell therapy/tissue engineering.
Y. Alinejad (2018)
10.1016/j.jconrel.2009.08.014
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
E. Lee (2009)
10.1016/j.biomaterials.2011.03.005
The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
Ran Mo (2011)
10.1111/fcp.12498
Melatonin as a potential modulator of Nrf2
Z. Ahmadi (2019)
10.1166/JBN.2015.2110
Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities.
J. Wu (2015)
10.1021/acs.molpharmaceut.7b00662
N-Deoxycholic acid-N,O-hydroxyethyl Chitosan with a Sulfhydryl Modification To Enhance the Oral Absorptive Efficiency of Paclitaxel.
Yanfang Yu (2017)
10.1021/la404493n
Dual-stimuli-responsive micelle of an ABC triblock copolymer bearing a redox-cleavable unit and a photocleavable unit at two block junctions.
Juan Xuan (2014)
10.1016/S1040-8428(02)00109-9
Weekly administration of paclitaxel: theoretical and clinical basis.
P. Marchetti (2002)
10.1016/j.msec.2018.11.044
Development of PSMA-targeted and core-crosslinked glycol chitosan micelles for docetaxel delivery in prostate cancer therapy.
X. Feng (2019)
10.1016/j.ijbiomac.2008.12.011
Synthesis of novel pH-sensitive chitosan graft copolymers and micellar solubilization of paclitaxel.
H. Li (2009)
10.1152/PHYSREV.1987.67.2.520
The physiology of transferrin and transferrin receptors.
H. Huebers (1987)
10.3109/03639045.2014.935390
Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy
J. Emami (2015)
10.1016/j.biomaterials.2014.05.053
Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
X. Wang (2014)
10.1016/J.CES.2007.08.006
Chemotherapeutic engineering : Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo
S. Feng (2007)
10.1016/j.biopha.2018.07.102
Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Mohamed M. Badran (2018)
10.1016/j.cub.2015.01.058
Chitin Is Endogenously Produced in Vertebrates
W. Tang (2015)
10.1016/J.COLSURFB.2006.04.009
Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel.
F. Hu (2006)
10.1016/J.JDDST.2019.03.017
Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades
Z. Ahmadi (2019)
10.1091/MBC.10.4.947
Taxol suppresses dynamics of individual microtubules in living human tumor cells.
A. Yvon (1999)
10.1023/A:1025513106330
Microtubules, microtubule-interfering agents and apoptosis
F. Mollinedo (2004)
10.1016/j.ejmech.2018.08.080
Nano-scale drug delivery systems for antiarrhythmic agents.
A. Nadimi (2018)
10.3390/molecules24020250
Chitosan-Coated Flexible Liposomes Magnify the Anticancer Activity and Bioavailability of Docetaxel: Impact on Composition
Mohammed O. Alshraim (2019)
10.1016/J.CARBPOL.2009.11.022
Preparation and characterization of PEG-cross-linked chitosan hydrogel films with controllable swelling and enzymatic degradation behavior
Hiroaki Tanuma (2010)
10.1016/j.canlet.2019.01.045
Aptamer-functionalized liposomes for targeted cancer therapy.
Seyedeh Alia Moosavian (2019)
10.2174/1567201816666191112113031
Nano-soldiers ameliorate silibinin delivery: A review study.
M. Ashrafizadeh (2019)
10.1016/0168-3659(94)00084-8
Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres
T. Park (1995)
10.1002/jps.21487
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
R. Yang (2009)
10.3390/vaccines3040803
Micelle-Based Adjuvants for Subunit Vaccine Delivery
Thomas Trimaille (2015)
10.1002/adma.200802106
Hydrogels in regenerative medicine.
B. V. Slaughter (2009)
10.1021/acs.molpharmaceut.7b00846
New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
R. Rosière (2018)
10.1016/j.jconrel.2008.02.003
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
H. Hwang (2008)
10.1111/j.2042-7158.2012.01482.x
Accelerated in‐vitro release testing methods for extended‐release parenteral dosage forms
Jie Shen (2012)
10.1016/j.ijbiomac.2017.02.030
Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Umesh Gupta (2017)
10.1016/j.phrs.2019.104551
Topoisomerase inhibitors: pharmacology and emerging nanoscale delivery systems.
A. Dehshahri (2019)
10.3109/10717544.2014.954281
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle
Mahboubeh Rezazadeh (2016)
10.1016/j.ejps.2009.01.004
PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
Guowei Qu (2009)
10.1038/nrc.2017.17
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip J. Gotwals (2017)
10.1002/jps.22159
Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system.
H. Li (2010)
10.1016/j.msec.2014.09.020
Effects of amphiphilic chitosan-g-poly(ε-caprolactone) polymer additives on paclitaxel release from drug eluting implants.
Weibin Shi (2014)
10.1155/2018/4607945
Biodegradable Alginate-Chitosan Hollow Nanospheres for Codelivery of Doxorubicin and Paclitaxel for the Effect of Human Lung Cancer A549 Cells
L. Tao (2018)
10.1080/10408347.2016.1236673
A Critical Review of Properties and Analytical Methods for the Determination of Oxytetracyline in Biological and Pharmaceutical Matrices
R. Sversut (2017)
10.1159/000096085
DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers
C. Ferreira (2006)
10.1016/j.ijpharm.2016.07.020
Heparin modification enhances the delivery and tumor targeting of paclitaxel-loaded N-octyl-N-trimethyl chitosan micelles.
Feiran Zhang (2016)
10.1007/s11596-009-0221-2
Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells
Yan Yang (2009)
10.1016/J.JCONREL.2005.09.026
Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
K. Obara (2005)
10.7326/0003-4819-111-4-273
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
W. Mcguire (1989)
10.1016/j.ejmech.2008.04.021
Targeting cancer cells with biotin-dendrimer conjugates.
W. Yang (2009)
10.2174/1566524019666191016150757
Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury.
M. Ashrafizadeh (2019)
10.1002/jbm.b.33636
Binary-copolymer system base on low-density lipoprotein-coupled N-succinyl chitosan lipoic acid micelles for co-delivery MDR1 siRNA and paclitaxel, enhances antitumor effects via reducing drug.
Shu-di Yang (2017)
10.1016/j.phrs.2019.03.023
Carbon nanomaterials and amyloid‐beta interactions: potentials for the detection and treatment of Alzheimer's disease?
M. Mohajeri (2019)
10.1002/ijc.32559
Boosting the apoptotic response of high‐grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro‐survival protein MCL‐1
M. Raab (2019)
10.1080/17425247.2019.1580691
Multi-functional chitosan-based smart hydrogels mediated biomedical application
M. Mu (2019)
10.1021/mp400282r
Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism.
H. Lian (2013)
10.1016/j.biomaterials.2008.12.083
Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
ChangJu Chun (2009)
10.1016/J.BIOMATERIALS.2007.11.029
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
C. Zhang (2008)
10.3390/ijms19103132
Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel
L. Li (2018)
10.1007/s11095-014-1395-2
Self-assembled Chitosan-Ceramide Nanoparticle for Enhanced Oral Delivery of Paclitaxel
G. Battogtokh (2014)
10.3109/10717544.2015.1045103
In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan
N. Liang (2016)
10.1016/j.ijpharm.2016.07.025
Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic imaging of cancer cells.
P. Manivasagan (2016)
10.1002/adma.201804041
Minimally Invasive and Regenerative Therapeutics.
N. Ashammakhi (2019)
10.1111/j.1742-4658.2009.06994.x
Possible binding site for paclitaxel at microtubule pores
M. Magnani (2009)
10.4103/0366-6999.226904
Effects of Paclitaxel-conjugated N-Succinyl-Hydroxyethyl Chitosan Film for Proliferative Cholangitis in Rabbit Biliary Stricture Model
Tao Wang (2018)
10.1016/j.jconrel.2008.01.013
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Kyung Hyun Min (2008)
10.3390/cells8101158
Nanoparticles Targeting STATs in Cancer Therapy
M. Ashrafizadeh (2019)
10.1016/j.nano.2019.102066
Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy.
Yingli Wang (2019)
10.1016/J.POWTEC.2015.04.053
Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer
Namdev L. Dhas (2015)
10.1021/bm2010774
Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
P. Lv (2011)
10.3109/10611861003733987
Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel
S. Sahu (2011)
10.1021/jm800767c
Conjugated chitosan as a novel platform for oral delivery of paclitaxel.
E. Lee (2008)
10.1016/S0169-409X(01)00239-3
Hydrogels for biomedical applications.
A. Hoffman (2002)
10.1016/j.ijpharm.2016.09.051
Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
S. Bano (2016)
10.4161/cbt.3.12.1223
Characterization of a specific phage-displayed peptide binding to vasculature of human gastric cancer
M. Zhi (2004)
10.1111/j.1445-5994.2006.01105.x
Docetaxel‐induced nasal septal perforation
T. H. Tan (2006)
10.1016/j.lfs.2018.10.048
Structural and functional aspects of P‐glycoprotein and its inhibitors
S. Mollazadeh (2018)
10.3109/1061186X.2014.930469
Self-assembled polymeric nanoparticle of PEGylated chitosan–ceramide conjugate for systemic delivery of paclitaxel
G. Battogtokh (2014)
10.1080/03639045.2017.1318895
Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells
J. Jiang (2017)
10.1038/nrc1317
Microtubules as a target for anticancer drugs
M. Jordan (2004)
10.1080/10408347.2017.1416283
Characteristics, Properties and Analytical Methods of Paclitaxel: A Review
Renata Carolina Alves (2018)
10.1080/03639045.2016.1220571
Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel
L. Shi (2017)
10.1016/j.msec.2019.01.006
Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions.
R. Augustine (2019)
10.2174/0929867324666170623093445
Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
N. B. Andriguetti (2017)
10.1016/j.nano.2019.102061
Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel Nanoconjugates that can pass the blood brain barrier.
Sirong Shi (2019)
10.1016/j.jconrel.2013.04.020
Oral delivery of anticancer drugs: challenges and opportunities.
K. Thanki (2013)
10.1016/j.msec.2019.03.002
Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects.
J. Choi (2019)
10.1016/j.biopha.2019.109225
Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin.
Shenghu Guo (2019)
10.1517/17425247.2015.1004309
Carbon nanotubes part II: a remarkable carrier for drug and gene delivery
Mahdi Karimi (2015)
10.3390/ijms19061550
Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation
N. Liang (2018)
10.1038/s41419-018-0594-x
Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer
Zhijie Lei (2018)
10.1111/cbdd.12814
Docetaxel–Chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study
Z. Mirzaie (2016)
10.1016/j.ijpharm.2013.09.021
Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery.
Joung-Pyo Nam (2013)
10.1208/ps010307
A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations
M. Shameem (2008)
10.1016/j.ejpb.2012.04.001
Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
V. Zabaleta (2012)
10.1016/j.carbpol.2017.11.096
Positively charged gold nanoparticles capped with folate quaternary chitosan: Synthesis, cytotoxicity, and uptake by cancer cells.
Hui-ju Yen (2018)
10.1002/ADMA.200501612
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology†
N. Peppas (2006)
10.1016/j.ijbiomac.2017.06.010
Hydrogel beads bio-nanocomposite based on Kappa-Carrageenan and green synthesized silver nanoparticles for biomedical applications.
S. Azizi (2017)
[Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
Meirong Huo (2006)
10.1021/nn2048526
Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy.
Hung-Wei Yang (2012)
10.1038/s41590-019-0433-y
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson (2019)
10.1007/3-540-45734-8_3
Degradable polymer microspheres for controlled drug delivery
U. Edlund (2002)
10.1021/acs.molpharmaceut.6b01068
Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Yanzuo Chen (2017)
10.1177/1758834017692779
Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting
J. Puente (2017)
Drug therapy : paclitaxel (Taxol)
E. Rowinsky (1995)
10.1002/ijc.29210
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
J. Ferlay (2015)
10.1016/J.BBAMEM.2005.10.008
Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics.
Cédric Klumpp (2006)
10.1016/j.jconrel.2012.08.005
Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
Silvia Mazzaferro (2012)
10.1016/S0076-6879(05)91018-5
Drug delivery by lipid cochleates.
L. Zarif (2005)
10.1021/acs.bioconjchem.7b00071
Tailored Chemical Properties of 4-Arm Star Shaped Poly(d,l-lactide) as Cell Adhesive Three-Dimensional Scaffolds.
C. K. Balavigneswaran (2017)
10.2147/IJN.S54413
Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability
W. M. Ibrahim (2014)
10.3390/molecules21010006
Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80
M. Mobasheri (2015)
10.29252/ibj.23.1.21
Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells
R. Jafari (2019)
10.1002/jcb.10661
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A. Ghosh (2004)
10.2147/IJN.S83508
The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes
Ya-Jing Ye (2015)
Spectrophotometric estimation of paclitaxel
Prashant Kesarwani (2011)
10.1016/j.biotechadv.2018.10.010
The Yin and Yang of carbon nanomaterials in atherosclerosis.
Mehdi Rezaee (2018)
10.1039/C8CP00124C
Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations.
Konda Reddy Karnati (2018)
10.1016/S0304-4157(96)00014-7
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
D. Richardson (1997)
10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
F. Bray (2018)
10.1016/j.msec.2019.02.018
Physiochemical and morphological dependent growth of NIH/3T3 and PC-12 on polyaniline-chloride/chitosan bionanocomposites.
Sara Abasi (2019)
10.1002/jcp.26899
Biomedical applications of carbon nanomaterials: Drug and gene delivery potentials
M. Mohajeri (2018)
10.1016/j.ijpharm.2015.11.032
Nanocomposite hydrogel incorporating gold nanorods and paclitaxel-loaded chitosan micelles for combination photothermal-chemotherapy.
N. Zhang (2016)
10.1016/j.ijbiomac.2019.04.071
Investigating the formulation of alginate- gelatin encapsulated Pseudomonas fluorescens (VUPF5 and T17-4 strains) for controlling Fusarium solani on potato.
Mojde Moradi Pour (2019)
10.1016/j.carbpol.2017.10.030
1, 3β-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy.
P. Singh (2018)
10.2147/IJN.S27823
Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid micelles
Feihu Wang (2012)
10.1016/j.carbpol.2017.10.066
N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel.
Meirong Huo (2018)
10.3109/10717544.2010.520355
In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel
J. Liu (2011)
10.1038/srep22149
Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
Wan-Jiang Xue (2016)
10.4103/JCRT.JCRT_267_17
Potential using of microRNA-34A in combination with paclitaxel in colorectal cancer cells
Hadis Soltani-Sedeh (2019)
10.1021/mp200278s
Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
S. H. Yuk (2012)
10.1021/acs.molpharmaceut.5b00696
Redox-Sensitive Micelles Based on O,N-Hydroxyethyl Chitosan-Octylamine Conjugates for Triggered Intracellular Delivery of Paclitaxel.
Meirong Huo (2016)
10.1016/J.APMT.2019.04.010
Status and future scope of plant-based green hydrogels in biomedical engineering
R. Mohammadinejad (2019)
10.1007/s13304-016-0359-y
Worldwide burden of colorectal cancer: a review
P. Favoriti (2016)
10.1038/srep41322
Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A
Min Liu (2017)
10.1016/j.biomaterials.2011.03.056
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening.
Tzyy-Harn Yeh (2011)
10.1186/s40199-016-0160-y
Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells
Nazanin Shabani Ravari (2016)
10.1155/2015/987404
A Redox-Sensitive Micelle-Like Nanoparticle Self-Assembled from Amphiphilic Adriamycin-Human Serum Albumin Conjugates for Tumor Targeted Therapy
L. Chen (2015)
10.1016/j.actbio.2017.02.012
Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
Rui He (2017)
10.1016/j.nano.2010.01.011
Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines.
S. Akhlaghi (2010)
10.1016/J.LWT.2016.12.006
Thyme essential oil loaded in nanocochleates: Encapsulation efficiency, in vitro release study and antioxidant activity
M. Asprea (2017)
10.1016/J.JCONREL.2004.08.010
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
10.2147/IJN.S26305
Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery
H. Lian (2011)
10.1016/j.colsurfb.2017.01.029
Synthesis and characterization of 3,6-O,O'- dimyristoyl chitosan micelles for oral delivery of paclitaxel.
D. Silva (2017)
10.2174/1389557516666160418123054
Clinical Application of Chitosan in Dental Specialities.
M. Wieckiewicz (2017)



This paper is referenced by
10.3390/biomedicines8010013
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
Shahryar Shakeri (2020)
10.1016/j.ijbiomac.2020.06.089
New organic/inorganic nanohybrids of targeted pullulan derivative/gold nanoparticles for effective drug delivery systems.
Sakchai Laksee (2020)
10.3390/molecules25030689
Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review
Mahshid Moballegh Nasery (2020)
10.1016/j.ijbiomac.2020.05.040
Magnetic nanoparticles double wrapped into cross-linked salep/PEGylated carboxymethyl cellulose; a biocompatible nanocarrier for pH-triggered release of doxorubicin.
S. H. Hosseini (2020)
10.1016/j.mtchem.2020.100295
Nanoparticles as an emerging tool to alter the gene expression: Preparation and conjugation methods
S. Thakur (2020)
10.3389/fphar.2020.01286
Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
Yuhao Zheng (2020)
10.1016/j.apmt.2020.100783
New horizons in benzothiazole scaffold for cancer therapy: Advances in bioactivity, functionality, and chemistry
P. C. Sharma (2020)
10.1016/j.ijbiomac.2020.10.013
An applied quantum-chemical model for genipin-crosslinked chitosan (GCS) nanocarrier.
Marjan Nasrabadi (2020)
10.1016/j.jconrel.2020.10.003
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation.
Wenxing Gu (2020)
10.2217/nnm-2020-0146
Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors.
M. Fathi (2020)
10.3390/ijms21030873
Optimization of Chitosan–Alginate Microparticles for Delivery of Mangostins to the Colon Area Using Box–Behnken Experimental Design
K. Mulia (2020)
10.1016/j.jconrel.2020.08.064
Functional gadolinium-based nanoscale systems for cancer theranostics.
Haonan Li (2020)
Semantic Scholar Logo Some data provided by SemanticScholar